STERIS (STE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
11 Jun, 2026Executive summary
Annual General Meeting scheduled for July 31, 2026, in Dublin, Ireland, with voting available online and in person.
Shareholders are encouraged to review proxy materials and vote on key proposals affecting governance and operations.
Voting matters and shareholder proposals
Election of nine directors, each recommended by the board for approval.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending March 31, 2027.
Appointment and remuneration of Ernst & Young Chartered Accountants as statutory auditor under Irish law.
Advisory vote to approve executive compensation as disclosed in the proxy statement.
Renewal of board authority to issue shares and opt-out of statutory pre-emption rights under Irish law.
Board of directors and corporate governance
Board recommends all director nominees for election at the meeting.
Proposals include renewal of board powers regarding share issuance and pre-emption rights.
Latest events from STERIS
- Record financial performance, strong governance, and key shareholder votes define this year's proxy.STE
Proxy filing11 Jun 2026 - Record 2026 revenue and EPS growth set up a strong 2027 outlook and $1B buyback.STE
Q4 202615 May 2026 - Strong recurring revenue and double-digit EPS growth outlook drive robust FY27 guidance.STE
Investor presentation13 May 2026 - Q3 revenue up 9% and adjusted EPS at $2.53; outlook steady despite tariff headwinds.STE
Q3 202613 Apr 2026 - Revenue up 8.1% to $1.28B, adjusted EPS at $2.03, and full-year outlook reaffirmed.STE
Q1 20252 Feb 2026 - Strong U.S. healthcare volumes and recurring revenue drive growth amid evolving global trends.STE
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q2 revenue up 7.3% and adjusted EPS at $2.14; FY25 outlook reaffirmed.STE
Q2 202515 Jan 2026 - Q3 revenue up 6% and adjusted EPS rises to $2.32; outlook narrowed on currency headwinds.STE
Q3 20258 Jan 2026 - Shareholders to vote on director re-elections, auditor appointments, and executive pay amid strong growth.STE
Proxy Filing1 Dec 2025